Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Accumulated Depreciation & Amortization (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Accumulated Depreciation & Amortization readings, the most recent being $1.9 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 1.77% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 million, a 1.77% increase, with the full-year FY2025 number at $1.9 million, up 1.77% from a year prior.
  • Accumulated Depreciation & Amortization hit $1.9 million in Q4 2025 for Arcadia Biosciences, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.7 million in Q4 2021 to a low of -$612000.0 in Q1 2023.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $2.6 million (2023), compared with a mean of $3.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: tumbled 112.24% in 2023 and later skyrocketed 502.29% in 2024.
  • Arcadia Biosciences' Accumulated Depreciation & Amortization stood at $5.7 million in 2021, then plummeted by 50.33% to $2.8 million in 2022, then crashed by 30.91% to $1.9 million in 2023, then decreased by 3.91% to $1.9 million in 2024, then rose by 1.77% to $1.9 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.